AMANTA vs NATCAPSUQ: Stock Comparison

AMANTA vs NATCAPSUQUpdated 16 Jun 26, 4:08 PM ISTNSE & company filings

AMANTA is the larger company by market capitalisation. AMANTA shows a higher ROE, a higher ROCE and a higher net margin, while NATCAPSUQ shows a lower P/E, faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

AMANTA leads 4; NATCAPSUQ leads 8 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

AMANTANATCAPSUQ

Valuation lens

What price are you paying?

Market CapContext only
₹749 Cr
₹187 Cr
P/E RatioNATCAPSUQ has the lower reading
53.58x
0x
P/B RatioNATCAPSUQ has the lower reading
3.57x
0.69x
EPSNATCAPSUQ has the higher reading
₹0.85
₹3.88
Book ValueContext only
₹56.71
₹225.45
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
AMANTA is the larger company
₹749 Cr vs ₹187 Cr
P/E Ratio
NATCAPSUQ has a lower P/E
0x vs 53.58x
P/B Ratio
NATCAPSUQ has a lower P/B
0.69x vs 3.57x
EPS
NATCAPSUQ has higher earnings per share
₹3.88 vs ₹0.85
Revenue Growth (TTM YoY)
NATCAPSUQ has faster revenue growth
30% vs 6.8%
EPS Growth (TTM YoY)
NATCAPSUQ has faster EPS growth
0% vs -23.4%
Qtr Sales Growth
NATCAPSUQ has stronger quarterly sales growth
-11.68% vs -76.08%
Qtr Profit Growth
NATCAPSUQ has stronger quarterly profit growth
170.27% vs -77.74%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricAMANTANATCAPSUQ
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricAMANTANATCAPSUQ
Live Price₹150.27₹216.18
Day Change-4.37%7.35%
Volume3.82 L32,916
52-Week High₹164₹296
52-Week Low₹92₹136.36
Distance from 52W High-8.37%-26.97%

Valuation

MetricAMANTANATCAPSUQ
Market Cap₹749 Cr₹187 Cr
P/E Ratio53.58x0x
P/B Ratio3.57x0.69x
EPS₹0.85₹3.88
Book Value₹56.71₹225.45
Dividend Yield0%0%

Growth

MetricAMANTANATCAPSUQ
Revenue Growth (TTM YoY)6.8%30%
EPS Growth (TTM YoY)-23.4%0%
Qtr Sales Growth-76.08%-11.68%
Qtr Profit Growth-77.74%170.27%

Profitability & Leverage

MetricAMANTANATCAPSUQ
ROE6.75%-10.51%
ROCE7.89%-4.87%
Net Margin5.17%-13.17%
Operating Margin14.55%-9.07%
Debt to Equity1.06x0.49x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricAMANTANATCAPSUQ
Promoter Holding26.87% 0.06 pp50.92% 0.12 pp
FII Holding0.43% 0.42 pp0%
DII Holding12.92% 0.04 pp0%
Public Holding22.85% 0.29 pp49.08% 0.12 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: AMANTA and NATCAPSUQ.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.